Creative Medical Technology
CELZ | NASDAQ
$0.52
-$0.01 (-1.53%)
At close: Nov 16, 2026, 4:00 PM ET
$0.52
$0.00 (+0.02%)
After-hours:
Nov 16, 2026, 7:55 PM ET
Creative Medical Technology Company Profile
Company profile explainedCompany Profile
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Key Executives
| Name | Position |
|---|---|
| Timothy Warbington | Co-Founder, Chairman, President & Chief Executive Officer |
| Donald Dickerson | Senior Vice President, Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 01, 2026 | SC 13D | Filing |
| Sep 25, 2026 | 4 | Filing |
| Sep 25, 2026 | 8-K | Current Report |
| Aug 31, 2026 | 8-K | Current Report |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 03, 2026 | 424B3 | Filing |
| Jul 31, 2026 | EFFECT | Filing |
| Jul 24, 2026 | S-3 | Filing |
| Jul 14, 2026 | DEF 14A | Filing |
| Jul 02, 2026 | 8-K | Current Report |
Creative Medical Technology
| Country | United States |
| IPO Date | Nov 6, 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Timothy Warbington |
Contact Details
211 East Osborn Road Phoenix,
Arizona 85012 United States
Stock Details
| Ticker Symbol | CELZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001187953 |
| CUSIP Number | 22529Y408 |
| ISIN Number | US22529Y4089 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove CELZ